share_log

Head-To-Head Analysis: Bio-Rad Laboratories (NYSE:BIO.B) Versus Cue Health (NASDAQ:HLTH)

Head-To-Head Analysis: Bio-Rad Laboratories (NYSE:BIO.B) Versus Cue Health (NASDAQ:HLTH)

正面分析:Bio-Rad實驗室(紐約證券交易所代碼:BIO.B)與Cue Health(納斯達克代碼:HLTH)
Defense World ·  2022/09/30 01:21

Bio-Rad Laboratories (NYSE:BIO.B – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Bio-Rad實驗室(紐約證券交易所代碼:BIO.B-GET評級)和Cue Health(納斯達克:HLTH-GET評級)都是醫療公司,但哪一家是更好的投資?我們將根據這兩家公司的盈利能力、股息、機構所有權、收益、分析師建議、估值和風險的強弱進行比較。

Insider & Institutional Ownership

內部人與機構所有權

0.0% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 37.9% of Cue Health shares are held by institutional investors. 28.4% of Bio-Rad Laboratories shares are held by insiders. Comparatively, 29.4% of Cue Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Bio-Rad實驗室0.0%的股份由機構投資者持有。相比之下,機構投資者持有Cue Health 37.9%的股份。Bio-Rad實驗室28.4%的股份由內部人士持有。相比之下,Cue Health 29.4%的股份由內部人士持有。強大的機構持股表明,對衝基金、捐贈基金和大型基金經理相信,從長期來看,一隻股票的表現將好於大盤。

Get
到達
Bio-Rad Laboratories
Bio-Rad實驗室
alerts:
警報:

Profitability

盈利能力

This table compares Bio-Rad Laboratories and Cue Health's net margins, return on equity and return on assets.

此表比較了Bio-Rad實驗室和Cue Health的淨利潤率、股本回報率和資產回報率。

Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories -67.66% 3.82% 2.84%
Cue Health -6.24% 5.50% 3.99%
淨利潤率 股本回報率 資產回報率
Bio-Rad實驗室 -67.66% 3.82% 2.84%
球杆健康 -6.24% 5.50% 3.99%

Earnings and Valuation

收益和估值

This table compares Bio-Rad Laboratories and Cue Health's top-line revenue, earnings per share and valuation.
這張表格比較了Bio-Rad實驗室和Cue Health的營收、每股收益和估值。
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bio-Rad Laboratories $2.92 billion 4.25 $4.25 billion ($66.32) -6.31
Cue Health $618.11 million 0.70 $86.42 million ($0.30) -9.77
總收入 價格/銷售額比 淨收入 每股收益 市盈率
Bio-Rad實驗室 29.2億美元 4.25 42.5億美元 ($66.32) -6.31
球杆健康 6.1811億美元 0.70 8642萬美元 ($0.30) -9.77

Bio-Rad Laboratories has higher revenue and earnings than Cue Health. Cue Health is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Bio-Rad實驗室的收入和收益比Cue Health更高。Cue Health的市盈率低於Bio-Rad實驗室,這表明它目前是兩隻股票中更負擔得起的一隻。

Analyst Recommendations

分析師建議

This is a breakdown of current ratings and price targets for Bio-Rad Laboratories and Cue Health, as reported by MarketBeat.

這是MarketBeat報道的Bio-Rad實驗室和Cue Health的當前評級和目標價的細目。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories 0 0 0 0 N/A
Cue Health 0 1 0 0 2.00
銷售評級 保持評級 購買評級 強勁的買入評級 評級分數
Bio-Rad實驗室 0 0 0 0 不適用
球杆健康 0 1 0 0 2.00

Cue Health has a consensus price target of $8.67, suggesting a potential upside of 195.79%. Given Cue Health's higher possible upside, analysts plainly believe Cue Health is more favorable than Bio-Rad Laboratories.

Cue Health的共識目標價為8.67美元,這意味着潛在的上漲幅度為195.79。考慮到Cue Health更有可能的上行空間,分析師們顯然認為Cue Health比Bio-Rad實驗室更有利。

Summary

摘要

Cue Health beats Bio-Rad Laboratories on 7 of the 11 factors compared between the two stocks.

Cue Health在兩隻股票之間進行比較的11個因素中,有7個超過了Bio-Rad實驗室。

About Bio-Rad Laboratories

關於Bio-Rad實驗室

(Get Rating)

(獲取評級)

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bio-Rad實驗室公司在美國、歐洲、亞洲、加拿大和拉丁美洲製造和分銷生命科學研究和臨牀診斷產品。該公司通過生命科學和臨牀診斷部門開展業務。生命科學部門開發、製造和營銷一系列試劑、儀器和實驗室儀器,用於研究技術、生物製藥生產過程和食品檢測制度。它專注於蛋白質組學、基因組學、生物製藥生產、細胞生物學和食品安全等生命科學市場的部分領域。這一細分市場為大學和醫學院、工業研究組織、政府機構、製藥商、生物技術研究人員、食品生產商和食品檢測實驗室提供服務。臨牀診斷部門為診斷市場中的臨牀實驗室設計、製造、銷售和支持測試系統、信息學系統、測試工具包和專門的質量控制。這一細分市場提供試劑、儀器和軟件,以滿足體外診斷測試市場中的特定利基市場。它向參考實驗室、醫院實驗室、國家新生兒篩查機構、醫生辦公室實驗室和輸血實驗室銷售產品。此外,該公司還提供分離複雜化學和生物材料以及識別、分析和提純成分的產品和系統。該公司通過其直銷隊伍,以及通過分銷商、代理商、經紀人和轉售商提供產品。Bio-Rad實驗室公司成立於1952年,總部設在加利福尼亞州大力神。

About Cue Health

關於Cue Health

(Get Rating)

(獲取評級)

Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

CUE Health Inc.是一家醫療保健技術公司,為個人、企業、醫療保健提供者和付款人以及公共衞生機構設計和開發診斷測試診斷平臺。該公司提供由硬件和軟件組件組成的Cue集成護理平臺,例如由Cue Reader(便攜式可重複使用的讀取器)、Cue Cartridge(一次性測試墨盒)和Cue Wand(樣本採集棒)組成的Cue Health Monitor System;Cue Data and Innovation Layer,具有基於雲的數據和分析能力的解決方案;Cue虛擬護理交付應用,包括Cue Health App和Cue Enterprise Dashboard;以及Cue Ecoessis集成和應用,允許與第三方應用和傳感器集成。它還為CUE健康監測系統提供新冠肺炎檢測試劑盒,該公司前身為CUE Inc.,並於2017年12月更名為Cue Health Inc.。CUE Health Inc.成立於2010年,總部設在加利福尼亞州聖地亞哥。

Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

每天收到Bio-Rad實驗室的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Bio-Rad實驗室和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論